Originally published in Boston Business Journal on November 17, 2021
![](https://www.massbio.org/wp-content/uploads/2021/11/Screenshot-2021-11-17-130856-1200x783.png)
While biopharmaceutical companies have begun to implement diversity, equity and inclusion initiatives, representation of people of color — particularly Black, brown and Indigenous workers — still lags, according to a new report.